REward SYSTem in Autism Spectrum Disorder and Addictive Disorder
RESYSTAA
Stimuli Sociaux Et Non-sociaux Du Système De Récompense : Une Étude En IRM Chez Des Sujets Avec Trouble Du Spectre De L'autisme Et Des Sujets Avec Un Trouble Addictif À L'alimentation. - RESYSTAA
3 other identifiers
interventional
78
1 country
3
Brief Summary
An MRI Study in Subjects with Autism Spectrum Disorder and Subjects with Food Addictive Disorder compared to healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedStudy Start
First participant enrolled
July 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 27, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 27, 2027
December 6, 2024
December 1, 2024
3 years
May 20, 2022
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Oxygene Level Dependent (BOLD) MRI signal
Measurement in fMRI of the BOLD signal for each condition (interest, addiction, social) will be carried out in order to highlight the possible alterations of the reward system, in particular at the level of the striatum in terms of cerebral activation for each of the groups of subjects. (FAD, ASD and HV).
At inclusion
Secondary Outcomes (2)
Tolerance to an MRI examination for FAD with overweight or obesity
At inclusion
Regulation of sensory, an fMRI measurement of the BOLD physiological signal for sensory responses (sensory block) in terms of brain activation in patients
At inclusion
Study Arms (3)
Autism Spectrum Disorder
EXPERIMENTALCharacterized by two main diagnostic criteria: a socio-emotional deficit via a defect in communication and social reciprocity, and a behavioral deficit which manifests itself in repetitive behavioral patterns (stereotypes), restricted interests and/or activities.
Food Addictive Disorders
ACTIVE COMPARATORCharacterized by regroup substance use disorders and behavioral addictions, are characterized in particular by the repeated occurrence of compulsive behavior and impaired social functioning
Healthy volonteers
PLACEBO COMPARATORAdult without neurological and psychiatric history, absence of progressive somatic pathologies or with vital risk.
Interventions
an fMRI measurement of the BOLD physiological signal for sensory responses
These tests, through videos with a social or non-social content (human presence or absence on the stereoscopic projection), will allow us to study two types of sensorialities (visual and interoceptive). Thus, it will be possible to obtain inter- and exteroceptive profiles of the participants, a direct reflection of the processing of the internal bodily sensations of the body.
Eligibility Criteria
You may qualify if:
- Arm A ˗ Concerning ASD patients: Adult carrying the diagnosis of ASD (DSM-5, ADOS, ADI-R criteria)
- Arm B ˗ Concerning FAD patients: Adult diagnosed with FA presenting with food addiction (DSM-5, YFAS 2.0, BES \>= 18 criteria).
- Arm C ˗ Concerning healthy volunteers : Adult with no neurological and psychiatric history , absence of progressive somatic pathologies or with vital risk.
- For all participants:
- Age greater than or equal to 18 years old
- Without intellectual delay (IQ \> 70).
- Able to understand and apply the instruction when an active task is proposed, according to the estimate of the investigator.
- Free, express, informed and written consent of the participant.
- Participant affiliated to a social security scheme
You may not qualify if:
- Neuromotor disorders.
- Visual disturbances not corrected or incompatible with MRI.
- Known epilepsy.
- Current substance use disorder with emotional distress/significant impact on functional outcome
- Rare genetic syndrome.
- Contraindications to MRI (other than body circumference)
- For women of childbearing age: negative urine or blood pregnancy test
- Person subject to a measure of judicial protection (safeguard of justice, curatorship, guardianship or family authorization)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Tourslead
- INSERM UMR-1253, Tours, Francecollaborator
Study Sites (3)
Center-Val de Loire Region Autism Resource Center
Tours, 37044, France
University Addictology Service, Liaison Team and Addictology Care
Tours, 37044, France
University Hospital, Medical Imaging Service
Tours, 37044, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frédéric BRIEND, PhD
University Hospital,Tours -INSERM U1253 iBrain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2022
First Posted
May 25, 2022
Study Start
July 27, 2023
Primary Completion (Estimated)
July 27, 2026
Study Completion (Estimated)
January 27, 2027
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share